LAFLAMME, ANNE, CAMILLE,CONNOR, BRONWEN, JANE,O'SULLIVAN, DAVID,OSULLIVAN, DAVID
申请号：
EP11810107
公开号：
EP2588112A4
申请日:
2011.06.28
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
The present invention relates to a pharmaceutical formulation for use in the treatment of at least one symptom of multiple sclerosis, wherein the formulation comprises the drug risperidone and/or clozapine.
